Cargando…
What do biomarkers tell us about the pathogenesis of ankylosing spondylitis?
Biomarkers may provide information that promotes understanding of prognosis, disease activity, and pathogenesis in ankylosing spondylitis. Biomarkers reflecting disease activity (metallo-proteinase-3) and inflammatory lesions on magnetic resonance imaging predict new bone formation and are ameliorat...
Autor principal: | Maksymowych, Walter P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688221/ https://www.ncbi.nlm.nih.gov/pubmed/19183433 http://dx.doi.org/10.1186/ar2565 |
Ejemplares similares
-
Update on the treatment of ankylosing spondylitis
por: Maksymowych, Walter P
Publicado: (2007) -
What Do Antibody Studies Tell Us about Viral Infections?
por: Ilinykh, Philipp A., et al.
Publicado: (2022) -
Childhood Wheeze Patterns: What Do They Tell Us?
por: McEvoy, Cindy T., et al.
Publicado: (2022) -
What do measurements of molecular biomarkers in different body fluids really tell us?
por: Poole, A Robin
Publicado: (2011) -
What do animal models tell us about the role of EBV in the pathogenesis of multiple sclerosis?
por: Hassani, Asma, et al.
Publicado: (2022)